# CHOCOlate MeLatonin for AdolescenT MigrainE

> **NCT03597529** · PHASE2 · COMPLETED · sponsor: **Amy Gelfand** · enrollment: 84 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT03597529
- **Lead sponsor:** Amy Gelfand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-25
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597529, "CHOCOlate MeLatonin for AdolescenT MigrainE". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03597529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*